Jazz Pharmaceuticals plc
Last updated September 27, 2026
Organization details
- Legal name
- Jazz Pharmaceuticals plc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Ireland
- Headquarters city
- Dublin
- Headquarters country
- Ireland
- Fiscal year end
- December
- Ticker symbol
- JAZZ
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001232524
- EIN
- 98-1032470
Board of directors
-
Anne ORiordan · DirectorSince 2023
-
Bruce C. Cozadd · Director · Chairman & CEOSince 2023
-
Catherine A. Sohn · DirectorSince 2023
-
Heather Ann McSharry · DirectorSince 2023
-
Jennifer E. Cook · DirectorSince 2023
-
Kenneth W. O'Keefe · DirectorSince 2023
-
Laura Hamill · DirectorSince 2024
-
Mark Douglas Smith · DirectorSince 2023
-
Norbert G. Riedel · DirectorSince 2023
- Since 2023
-
Patrick Kennedy · DirectorSince 2024
-
Peter Gray · DirectorSince 2023
-
Rick E. Winningham · DirectorSince 2023
-
Seamus Mulligan · DirectorSince 2023
-
Ted W. Love · DirectorSince 2025
Chief executives
Bruce C. Cozadd
· Chairman & CEO
Dates unknown
Director election results
Annual meeting of July 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.5%
-
96.1%
-
96.2%
Board connections
7 of this board's directors also sit on 17 other boards.
- via Catherine A. Sohn
- via Laura Hamill
- via Patrick G. Enright
- via Jennifer E. Cook
- via Jennifer E. Cook
- via Norbert G. Riedel
- via Laura Hamill
- via Ted W. Love
- via Catherine A. Sohn
- via Mark Douglas Smith
- via Ted W. Love
- via Laura Hamill
- via Ted W. Love
- via Mark Douglas Smith
- via Patrick G. Enright
- via Patrick G. Enright
- via Patrick G. Enright
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $68,716,207
- 59 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 10, 2026 | Neena M. Patil Officer (EVP & Chief Legal Officer) | Open-market sale | −1,200 | $240.94 | $289,128 |
| Sep 8, 2026 | Renee D. Gala Officer (President & CEO) | Shares withheld for tax | −1,967 | $246.81 | $485,475 |
| Sep 8, 2026 | Henderson Mary Elizabeth Officer (SVP, Technical Operations) | Shares withheld for tax | −1,412 | $243.03 | $343,158 |
| Sep 8, 2026 | Renee D. Gala Officer (President & CEO) | Open-market sale | −2,000 | $243.03 | $486,060 |
| Sep 8, 2026 | Henderson Mary Elizabeth Officer (SVP, Technical Operations) | Shares withheld for tax | −15 | $241.20 | $3,618 |
| Sep 1, 2026 | Bruce C. Cozadd Director | Open-market sale | −6,000 | $250.13 | $1,500,780 |
| Aug 31, 2026 | Bruce C. Cozadd Director | Shares withheld for tax | −10 | $244.06 | $2,441 |
| Aug 31, 2026 | Jennifer E. Cook Director | Shares withheld for tax | −14 | $244.06 | $3,417 |
| Aug 31, 2026 | Patrick G. Enright Director | Shares withheld for tax | −14 | $244.64 | $3,425 |
| Aug 31, 2026 | Laura Hamill Director | Shares withheld for tax | −14 | $244.06 | $3,417 |
| Aug 31, 2026 | Henderson Mary Elizabeth Officer (SVP, Technical Operations) | Shares withheld for tax | −2,076 | $241.39 | $501,126 |
| Aug 31, 2026 | Norbert G. Riedel Director | Shares withheld for tax | −14 | $244.64 | $3,425 |
| Aug 31, 2026 | Ted W. Love Director | Shares withheld for tax | −6 | $244.06 | $1,464 |
| Aug 31, 2026 | Rick E. Winningham Director | Shares withheld for tax | −1,692 | $241.39 | $408,432 |
| Aug 31, 2026 | Heather Ann McSharry Director | Shares withheld for tax | −15 | $244.64 | $3,670 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.